Staff editor
We discussed the rationale of probiotics in urogenital female healthcare and after pregnancy with gynaecologist Franco Vicariotto.
NEXT-GEN PROBIOTICS, PREBIOTICS AND POSTBIOTICS: WHO, WHAT & WHY? Probiotics This session will underline the advances of research and clinical applications of probiotics, stimulating the discussion on: Probiotics 2.0: new…
We discussed the dermobiotic approach with Marco Pignatti (Dermatologist, University of Modena, Italy).
PharmaBiome has developed unique technologies to access the entire range of intestinal bacteria. We met Christophe Lacroix, Founder of Pharmabiome.
ProDigest recreates the gastrointestinal tract to assess the mechanism of action of components such as prebiotics, probiotics or drugs.
We discussed the role of the microbiome in HPV-positive head and neck cancer patients with Marc Oliva Bernal (Institut Català d’Oncologia, Spain).
Does the microbiota contribute to breast cancer development? We asked this question to Sridhar Mani, from the Albert Einstein College of Medicine in New York (USA).
Rémy Burcelin explains how understanding the link between gut microbiota, metabolic syndrome and cancer could be useful from a therapeutic point of view.
CosmosID detects and identifies microorganisms of all kinds using next-generation sequencing. We discussed CosmosID's approach with Arne Materna, the company's VP Product.
Radiotherapy against prostate cancer may cause serious intestinal side effects. We discussed the impact of the local microbiota with Miguel Reis Ferreira.
